🔒 Private Beta
This site is password protected
VIRPrep is currently in private setup mode. Enter the site password to continue.
Site Password
778
Questions
160
Mock Exam
5
Categories
Welcome to VIRPrep
Enter your beta access code to study, or request access below.
Access Code
Don't have a code?
Request Beta Access
Tell us about yourself. We review every request personally and respond within 24 hours.
Full Name *
Email Address *
Credential / Role
Why do you want access?
📬
Request Submitted!
We review every request personally. If approved, you'll receive your access code by email within 24 hours.

Already have a code?
✦ The Only Dedicated VI Registry Prep Platform

Pass the VI Registry.
The first time.

Built by VI techs. Every question sourced from ARRT® content specs, SIR guidelines, and ACR clinical standards. Not a textbook. A pass machine.

778
Questions
160
Mock Exam
5
Categories
100%
ARRT Aligned
No credit card until launch  ·  Works on any device  ·  Progress saves automatically
ARRT® Content Specifications
SIR Consensus Guidelines 2019
ACR Manual on Contrast Media 2024
NCRP Report 168
AASLD Guidelines 2021
Updated 2026

Everything you need. Nothing you don't.

Other prep products give you PDFs and static flashcards. VIRPrep gives you an adaptive engine built for how the registry actually tests.

📋
Mock Registry Exam
160 questions at exact ARRT® proportions. Timed mode runs at 3h 30m — the real exam clock. Auto-submits when time expires.
🧠
Smart Spaced Repetition
SM-2 algorithm tracks every question you've seen. Surfaces the ones you keep missing at exactly the right time.
📊
Performance Analytics
Registry readiness score, per-category breakdown, trend chart, strengths vs. focus areas. Know exactly where you stand.
📖
Complete Study Guide
All 5 ARRT content areas. Anticoagulation tables, contrast protocols, vascular anatomy, exam traps, clinical scenarios. All in one place.
Flashcard Deck
Active recall from every high-yield topic. Flip to reveal, mark as learned, filter by category. Works on your phone during breaks.
🔖
Question Review
After every quiz, review every question — what you got right, what you missed, and why. The explanation alone is worth the price.

Built to the exact ARRT® blueprint.

The VI Registry has 160 scored questions across 5 content areas. VIRPrep mirrors those proportions exactly — so you study what's actually tested.

22
Patient Care
14% of exam
26
Image Production
16% of exam
42
Vascular Diagnostic
26% of exam
42
Vascular Interventional
26% of exam
28
Nonvascular
18% of exam

The honest comparison.

We looked at every VI prep product. Here's what we found.

Feature VIRPrep ExamEdge Textbooks
Dedicated VI Registry questions✓ 778
Detailed explanations for every answer
Full study guide (all 5 areas)
Spaced repetition algorithm
Timed mock exam (3h 30m)
Performance analytics dashboard
Price$99/year$174 (20 tests only)$80–120 (static)

One price. Everything included.

Less than $2 a week. Less than your coffee the morning of the exam.

Annual Plan — Best Value
$99
per year  ·  cancel anytime
778 registry-aligned practice questions
Full mock exam at exact ARRT® proportions
Timed mock — 3h 30m auto-submit
Complete study guide — all 5 content areas
Spaced repetition & smart review
Performance analytics & progress tracking
Flashcard deck & quick reference
Works on desktop, tablet, and phone
Updated continuously as guidelines change
Currently in private beta — early access pricing. Launch price may increase.

Frequently asked questions.

Is VIRPrep aligned with the current ARRT® VI exam?+
Yes. Every question is mapped to the current ARRT® Vascular-Interventional Radiography content specifications. Clinical values, drug doses, and procedural guidelines are updated to reflect current standards — SIR 2019, ACR 2024, AASLD 2021, and NCRP Report 168.
Does the exam have images or diagrams?+
No — the ARRT® VI registry exam is entirely text-based. No vessel identification from images, no diagrams. VIRPrep matches that format exactly. Every question is a clinical vignette or knowledge recall in text form.
How is VIRPrep different from a textbook?+
Textbooks are written for physicians and cover far more than the registry tests. VIRPrep is built specifically around what ARRT® actually asks — exam traps, clinical scenarios, the exact numbers you need to know. Active recall and spaced repetition are proven to outperform passive reading by a significant margin.
Does my progress save if I close the app?+
Yes. Your scores, bookmarks, spaced repetition data, and session history all save automatically — both locally and to our server. Pick up exactly where you left off on any device.
When does billing start?+
VIRPrep is currently in private beta. If you received an access code, you can use the app now. Full public launch with billing is coming soon. Early beta users will receive a discounted rate at launch.
What is the refund policy?+
We offer a 7-day money-back guarantee after launch. If VIRPrep isn't right for you, contact us within 7 days of purchase for a full refund — no questions asked.
Your registry exam is waiting.
Are you ready?
Join the VI techs who are preparing smarter — with a tool built specifically for this exam.
My Dashboard
Start studying. Your history is in the History tab.
Quick Start
📝
Build Exam
Choose categories, count, and options
Custom
📋
Mock Exam
160 Qs at exact ARRT® proportions
160 Qs
Timed Mock
160 Qs · 3h 30m · exact ARRT® simulation
3h 30m
🧠
Smart Review
Spaced repetition — questions due today
Adaptive
Bookmarked
Questions you saved for later review
0 saved
Timed Mode
60 sec/question from your weakest area
10 Qs
Quick 5
Five questions from your weakest category
5 Qs
Study Guide
All five ARRT® VI content areas — concise, clinical, exam-focused
Content Areas
22 Questions · 14% of Exam
Patient Care

Patient care is the highest-stakes section for clinical judgment. Expect questions on preprocedural assessment, contrast reactions, anticoagulation, pharmacology, and emergency management. Know the why — not just drug names and doses.

Why High-Yield

This section tests clinical decision-making in real IR scenarios. The exam loves questions where you must choose between similar drugs, recognize when a patient is deteriorating, or know which lab value to check before starting a procedure. Rote memorization fails here — pattern recognition wins.

Procedure Bleeding Risk — SIR Stratification
Risk LevelExample ProceduresINRPlatelets
LowPICC, IVC filter, paracentesis, thoracentesis, dialysis access, superficial biopsy, drain exchange<2.0>50,000/μL
ModerateArterial ≤7Fr, embolization, tunneled catheter, port, liver biopsy, abscess drainage, lung biopsy, spine<1.5>50,000/μL
HighTIPS, PTBD/nephrostomy (new), percutaneous renal biopsy<1.5>50,000/μL

Key rule: Paracentesis and thoracentesis = LOW risk. No INR correction required. This is a common exam trap.

Anticoagulation — Hold Times & Reversal
Hold Times (SIR 2019)
  • Aspirin — not held low/mod; hold 5 days high-risk
  • Clopidogrel — hold 5 days ALL procedures
  • DOACs — hold 2–3 days (renal function dependent)
  • UFH (IV) — stop 4 hours before + confirm PTT/ACT normalized
  • LMWH (enoxaparin) — hold 24 hours before
  • Warfarin — hold 5 days; INR day-of
Reversal Agents
  • Warfarin urgent — 4F-PCC (Kcentra); FFP if PCC unavailable
  • Dabigatran — idarucizumab (Praxbind)
  • Factor Xa inhibitors — andexanet alfa (Andexxa)
  • UFH — protamine sulfate 1mg per 100 units UFH
Contrast Reactions — Recognition & Treatment (ACR 2023)
SeverityKey SignsTreatment
MildLimited urticaria, flushing, nausea, single vomitObserve; diphenhydramine 25–50mg PO/IM PRN
ModerateDiffuse urticaria, mild bronchospasm, mild hypotensionO&sub2;, IV fluids; diphenhydramine IV; epi if progressing
AnaphylaxisBronchospasm, laryngeal edema, BP collapse, HR ↑Epinephrine FIRST — 0.3mg IM (1:1,000) lateral thigh
VasovagalHypotension + bradycardia, diaphoresis, pallorAtropine 0.6–1mg IV; elevate legs; fluids
Critical distinction: Anaphylaxis = tachycardia. Vasovagal = bradycardia. The heart rate tells you which drug to grab first. Epinephrine for anaphylaxis. Atropine for vasovagal. The exam will flip them.

Prior reaction risk multiplier: ~5× increased risk (NOT 10×) — ACR 2024. Premedication protocol: methylprednisolone 32mg PO at 12h and 2h before contrast.

Key IR Medications — Must-Know Facts
DrugClass/UseKey Exam Fact
Heparin (UFH)AnticoagulantReversed by protamine; monitor with aPTT or ACT
Alteplase (tPA)Thrombolytic (CDT)0.5–1 mg/hr intra-catheter; ABS CI: stroke <2 months
EpinephrineVasopressor/anaphylaxis0.3mg IM (1:1,000) — FIRST drug in anaphylaxis
AtropineAnticholinergic/vasovagal0.6–1mg IV — bradycardia/vasovagal; not for anaphylaxis
MidazolamBenzo/sedationReversed by flumazenil; respiratory depression risk
FentanylOpioid/analgesiaReversed by naloxone; shorter acting than morphine
NitroglycerinVasodilator100–200μg intra-arterial for vasospasm
VasopressinVasoconstrictor0.2–0.4 units/min intra-arterial for GI bleed embolization
Exam Traps — Patient Care
  • Trap: Paracentesis/thoracentesis require INR correction FALSE. Both are LOW risk. No threshold. No correction needed.
  • Trap: Prior contrast reaction = 10× risk FALSE. It’s ~5× (ACR 2024).
  • Trap: Vasovagal gets epinephrine FALSE. Vasovagal = bradycardia = atropine. Epi is for anaphylaxis (tachycardic).
  • Trap: UFH held 6 hours before procedure FALSE. SIR 2019 says 4 hours + confirm PTT/ACT normalized.
  • Trap: Warfarin reversed with FFP first FALSE. 4F-PCC (Kcentra) is preferred for urgent reversal.
  • Trap: Dabigatran reversed with vitamin K FALSE. Idarucizumab (Praxbind) is the specific reversal agent.
Clinical Scenarios
Scenario 1

Patient develops BP 70/40, HR 130, diffuse hives, and audible wheeze 90 seconds after contrast injection. First action?

Answer

Epinephrine 0.3mg IM (1:1,000) to lateral thigh — immediately. This is anaphylaxis. Tachycardia distinguishes it from vasovagal.

Scenario 2

INR is 1.8 day-of-procedure for a scheduled paracentesis. Procedure coordinator asks if you should delay. Your answer?

Answer

Proceed. Paracentesis is LOW bleeding risk. No INR threshold applies. Delaying is incorrect.

Scenario 3

Patient on dabigatran needs emergent TIPS for variceal bleed. How do you reverse anticoagulation?

Answer

Idarucizumab (Praxbind) — the specific reversal agent for dabigatran. 4F-PCC is for warfarin.

Scenario 4

BP drops to 85/50, HR slows to 48, patient becomes pale and diaphoretic mid-procedure (no contrast given). What is this and how do you treat it?

Answer

Vasovagal reaction. Bradycardia is the key. Atropine 0.6–1mg IV + leg elevation + fluids. NOT epinephrine.

Preprocedure Communication & Universal Time-Out
The 3-Part Preprocedure Conversation
  • Explanation of procedure — reinforce what the physician explained; what patient will feel, duration, recovery
  • Radiation risk — explain ALARA, fluoroscopy use, skin injury risk at doses ≥5 Gy; required in consent for high-dose cases
  • Time-out (Universal Protocol) — entire team together, immediately before procedure
Time-Out Checklist (JC Universal Protocol)
  • Two patient identifiers: name + DOB or MRN
  • Correct procedure and site confirmed
  • Relevant imaging available on PACS
  • Correct devices/implant sizes available
  • Allergies confirmed, antibiotics given if indicated
  • All team members verbally agree — if anyone objects, procedure stops
Exam Trap: The time-out is performed by the entire team together — not the physician alone before entering the room.
Informed Consent & Emergent Consent
TypeWhen UsedKey Rules
Informed (written)All elective proceduresMust be obtained before sedation; patient must understand risks, benefits, alternatives, right to refuse
VerbalMinor additions mid-procedureMust be documented in medical record immediately
Emergent (implied)Incapacitated patient, life-threatening emergencyLegal presumption reasonable person would consent; document clinical status + absence of surrogate; contact family ASAP
Critical: A sedated patient cannot give new consent. Consent must be obtained before sedation begins.
Access Assessment — Allen Test & Barbeau Test
Allen Test (Radial Access Safety)
  1. Compress both radial and ulnar arteries; patient opens/closes fist to exsanguinate
  2. Release ulnar artery only
  3. Normal (<7 sec): color returns → adequate ulnar collateral → radial access safe
  4. Abnormal (>7–10 sec): inadequate collateral → radial access contraindicated
Barbeau Test (SpO&sub2; Waveform)
  • Type A: No change after radial compression → excellent collateral → proceed
  • Type B: Dampened then recovers → acceptable
  • Type C: Lost then recovers >2 min → borderline
  • Type D: Lost, does NOT recover → CONTRAINDICATED
NPO Status & Procedure Sequencing
IntakeMinimum Hold Before Procedure
Clear liquids2 hours
Breast milk4 hours
Light meal / nonhuman milk6 hours
Full meal / fatty food8 hours
Sequencing Rules
  • Nuclear scan + angiography same day → nuclear scan first (contrast reduces isotope uptake)
  • Biopsy + ablation same session → biopsy first, confirm diagnosis, then ablate
  • Metformin + contrast → hold metformin 48h if eGFR <60
  • Dialysis + contrast → arrange same-day dialysis after contrast if possible
ECG Monitoring & Rhythm Recognition
RhythmRecognitionAction
Normal sinusRegular 60–100 bpm, P before every QRSContinue
Sinus bradycardiaRate <60, otherwise normalAtropine if symptomatic (BP drop, altered MS)
Sinus tachycardiaRate >100, P waves presentAssess cause: pain, anxiety, hypovolemia, contrast reaction
PVCsWide bizarre QRS, no preceding P waveOccasional = normal; frequent/multifocal → notify physician
Atrial fibrillationIrregularly irregular, no P wavesNotify physician; rate assessment
Ventricular tachycardiaWide QRS >100 bpm, regularPulseless → defibrillate; pulsatile → amiodarone
Ventricular fibrillationChaotic, no organized QRSImmediate defibrillation + CPR
Capnography & Oxygen Delivery
Capnography (EtCO&sub2;)
  • Measures end-tidal CO&sub2; — reflects alveolar ventilation
  • Normal EtCO&sub2;: 35–45 mmHg
  • Detects respiratory depression 30–90 sec before SpO&sub2; drops
  • Flat waveform = apnea → stimulate, jaw thrust, reversal agents immediately
  • Recommended for ALL patients receiving moderate sedation
O&sub2; Delivery Devices
  • Nasal cannula: 1–6 L/min → 24–44% FiO&sub2; (standard for sedation)
  • Simple face mask: 6–10 L/min → 35–55% (min 6 L to flush CO&sub2;)
  • Non-rebreather: 10–15 L/min → 60–90% (significant hypoxia)
  • BVM: up to 100% → apnea/respiratory arrest
Exam Trap: SpO&sub2; of 97% does NOT mean breathing is adequate — capnography can show apnea while SpO&sub2; still reads normal. Flat EtCO&sub2; = act immediately.
Controlled Substance Management
DEA Schedules (IR-relevant)
  • Schedule II: Fentanyl, hydromorphone, morphine — highest abuse potential; two-person verification required
  • Schedule IV: Midazolam (Versed), lorazepam — require documentation
Wasting Protocol
  • Two qualified staff must be present for preparation AND waste
  • Witness physically observes waste — both sign the log
  • Waste immediately in sink or sharps-safe disposal — cannot be saved
  • Discrepancy → immediate supervisor notification → mandatory investigation
  • Diversion = federal criminal offense + license revocation
Radiation Risk Communication
  • Tech reinforces physician's consent discussion — does not replace it
  • Explain: fluoroscopy uses ionizing radiation; ALARA techniques minimize dose
  • High-dose procedures (EVAR, TIPS, complex embolization): formal radiation risk is part of written consent
  • NCRP SRDL: 5 Gy cumulative air kerma — threshold for mandatory patient notification and follow-up
  • Young patients (especially women): higher radiosensitivity of breast, ovary, thyroid — acknowledge and explain dose reduction steps
  • Never say “no risk” — but contextualize: benefit typically far outweighs small statistical risk
Medical Equipment Monitoring
EquipmentKey Monitoring PointsAction if Problem
IV accessSite patency, no swelling/pain (infiltration)Stop injection; assess; notify physician if extravasation
Drainage bagsMust stay below patient level at all timesElevated bag → retrograde flow → infection risk
Chest tubeOutput color/volume, water seal intact, no new air leakZero output → check for kink/obstruction; never clamp without order
SuctionYankauer tip at bedside for all sedation casesVerify functional before starting any sedation procedure
OxygenSpO&sub2; + EtCO&sub2; together; escalate O&sub2; if SpO&sub2; <92%SpO&sub2; not improving on cannula → upgrade to non-rebreather mask
Quick Recall — Patient Care
  • Epinephrine 0.3mg IM (1:1,000) → anaphylaxis (tachycardic)
  • Atropine 0.6–1mg IV → vasovagal (bradycardic)
  • UFH: stop 4h + normalize PTT/ACT — NOT 6 hours
  • Clopidogrel: 5 days ALL procedures, no exceptions
  • Prior contrast reaction: ~5× risk (not 10×) — ACR 2024
  • Paracentesis & thoracentesis: LOW risk — no INR correction
  • Dabigatran reversal: idarucizumab  |  Factor Xa reversal: andexanet alfa
  • Urgent warfarin reversal: 4F-PCC first, FFP if PCC unavailable
26 Questions · 16% of Exam
Image Production

Image production tests your understanding of fluoroscopy physics, radiation safety, DSA technique, and equipment operation. The exam rewards techs who know why dose increases, not just which button to press.

Why High-Yield

This section has predictable, testable numbers (dose thresholds, scatter geometry, ALARA principles). If you know the 5 Gy Ka,r notification threshold, the 15 Gy tissue injury threshold, and the geometry of scatter radiation — you will answer most questions correctly. DSA artifact causes are also heavily tested.

Radiation Dose — NCRP Thresholds
ThresholdValueAction RequiredSource
SRDL notification5 Gy Ka,rNotify referring physician; follow-up at 30 & 60 daysNCRP Report 168
TJC Sentinel Event15 Gy PSDReport as sentinel event; skin injury likelyJoint Commission
Deterministic threshold2 Gy PSDTemporary erythema possibleNCRP 116
Permanent epilation7 Gy PSDPermanent hair loss possibleNCRP 116
Annual occupational limit50 mSv/yrWhole body; monitored with dosimeterNCRP 116
Cumulative lifetime limit10 mSv × ageOngoing monitoringNCRP 116
Fluoroscopy — ALARA Dose Reduction
Dose Reduction Techniques
  • Last image hold (LIH) — zero radiation, shows last frame
  • Pulsed fluoroscopy — reduces dose vs continuous
  • Collimation — reduces scatter and dose to patient
  • Maximum SID (source-to-image distance) — reduces dose
  • Minimum OID (object-to-image distance) — reduces magnification artifact
  • Remove grid for small patients — reduces dose
  • Low dose or pediatric mode
Dose Increase Factors
  • Smaller FOV (field of view) — MORE dose (AEC compensates)
  • Magnification mode — increases dose significantly
  • Steep oblique angles — increases patient dose
  • Continuous fluoroscopy vs pulsed
  • Larger patient habitus — AEC increases technique automatically
  • Boosted/high-dose mode
Scatter Radiation — Tube Position
X-ray Tube PositionScatter DirectionImplication
Tube above table (PA)Scatter goes downwardSafer for staff — scatter away from upper body
Tube below table (AP)Scatter goes upwardMore dose to operator face/eyes/thyroid
LAO/RAO steep anglesScatter toward operator sideStep back or use shield during acquisition
Rule: Tube above = scatter down = safer. Tube below = scatter up toward staff. For lateral projections, the operator closest to the tube gets the most scatter.
DSA — Digital Subtraction Angiography
IssueCauseFix
Misregistration artifactPatient movement between mask and fillReacquire mask; breath hold coaching
Motion blurHigh frame rate needed for fast vesselsIncrease frames/sec (cardiac DSA)
Road mapping errorPatient moved after road map acquiredRe-acquire road map
Pixel shiftingSmall misregistration; bowel gas movementRe-mask or reposition

DSA principle: Mask image (no contrast) is subtracted from live image (with contrast), leaving only the vessel. Any movement between mask and fill = misregistration = artifact.

Hydrodissection — Critical Drug Safety
D5W ONLY for RFA hydrodissection. Normal saline conducts electrical current and can cause inadvertent tissue damage. This is a common safety question. D5W = electrically inert = safe to use as a thermal/electrical barrier.
Exam Traps — Image Production
  • Trap: Smaller FOV = less dose FALSE. Smaller FOV = MORE dose (AEC increases technique to maintain brightness).
  • Trap: LIH uses a small radiation burst FALSE. Last image hold = ZERO radiation. It holds the last acquired frame.
  • Trap: Tube below table is safer for staff FALSE. Scatter goes upward toward face/thyroid. Tube above = safer.
  • Trap: DSA misregistration is caused by contrast injection rate FALSE. Misregistration is caused by patient movement between mask and fill.
  • Trap: Normal saline is used for RFA hydrodissection FALSE. D5W only — NS conducts electricity.
  • Trap: Maximum SID increases patient dose FALSE. Maximum SID reduces dose (inverse square law).
Clinical Scenarios
Scenario 1

Cumulative fluoroscopy time reaches 85 minutes in a complex TIPS. Ka,r reads 5.2 Gy. What is your obligation?

Answer

Notify the referring physician (SRDL threshold is 5 Gy Ka,r per NCRP 168). Schedule follow-up skin assessment at 30 and 60 days.

Scenario 2

During DSA run, the subtracted image shows a ghosting artifact that looks like overlapping vessel outlines. Most likely cause?

Answer

Patient movement between mask acquisition and contrast fill = misregistration artifact. Re-acquire the mask.

Scenario 3

You switch from 9-inch to 6-inch FOV during a procedure. What happens to the patient’s radiation dose?

Answer

Dose increases. Smaller FOV triggers AEC to increase technique (kVp/mA) to maintain image brightness. Counter-intuitive but critical.

Scenario 4

Physician asks for saline to use as hydrodissection fluid during renal RFA. Your response?

Answer

Decline and provide D5W instead. Saline conducts electrical current and creates a path for thermal/electrical injury. D5W is electrically inert.

PACS — Picture Archiving & Communication System
Core Components
  • Acquisition interface — receives images from fluoro/DSA/CT, assigns to patient
  • Archive (server) — long-term storage with redundant backup
  • Workstations — physician/tech viewing, multiplanar reconstructions
  • RIS integration — links order to image; confirms patient identity before imaging
  • DICOM standard — universal image format; header contains patient data, dose parameters
IR Workflow
  1. Patient registered → order placed in RIS
  2. Workstation confirms patient identity before imaging begins
  3. Images auto-sent to PACS after procedure
  4. Prior imaging retrieved from PACS for intraprocedural roadmapping comparison
  5. Physician reads from PACS; report entered in EMR
Automatic Pressure Injectors
ParameterTypical RangeClinical Point
Flow rate2–25 mL/secMust match vessel size; too fast → dissection
Volume5–50 mLEnough for arterial phase; minimize contrast load
Pressure limit150–1200 PSI5 Fr ≤600 PSI; 4 Fr ≤300 PSI; set per catheter size
Rise time0.1–0.5 secTime to reach target flow; shorter = more abrupt
CRITICAL: Power injectors are NEVER used with microcatheters (2.7–2.9 Fr) — pressure will rupture catheter or dissect vessel. Microcatheter = hand injection only.
  • Air detector stops injection automatically if air detected in syringe/tubing
  • Flush syringe/tubing with saline before contrast to remove air
  • Single patient use only — never reuse syringes or tubing
Procedural Equipment — IVUS, Ablation, Thrombectomy
IVUS (Intravascular Ultrasound)
  • 20–45 MHz catheter → 360° cross-sectional vessel image
  • Uses: IVC filter placement, TIPS guidance, stent apposition, dissection true/false lumen
  • Calcium = bright hyperechoic with posterior acoustic shadowing
  • Soft thrombus = low echogenicity, no shadowing
Ablation Comparison
  • RFA: ionic agitation → heat; grounding pads required; limited by charring; hydrodissection = D5W only
  • MWA: dielectric heating; no grounding pads; larger zones; not limited by charring; less heat-sink effect
  • Cryo: freeze-thaw ice ball; visible on CT; used near bile ducts/colon
Mechanical Thrombectomy Devices
  • Angiojet: rheolytic (Venturi effect); risk of hemolysis
  • Penumbra/Indigo: aspiration; continuous negative pressure
  • ClotTriever: large-bore mechanical removal for DVT
Intravascular Lithotripsy (Shockwave IVL)
  • Sonic pressure waves fracture calcified plaque without vessel injury
  • Balloon-based; allows subsequent DCB or stenting in calcified lesions
  • Available for peripheral (SFA, iliac) and coronary vessels
Radiation QC — Apron Integrity & Dose Calibration
Inspection TypeFrequencyWhat It Finds
Visual inspectionEach useVisible external tears, cracks
Fluoroscopic/radiographicAt least annuallyInternal lead discontinuities not visible externally
Remove from Service If:
  • Internal crack >1 cm in critical area (abdominal/gonadal region)
  • Any breach in lead lining confirmed on fluoroscopic inspection
  • No field repair method restores integrity — remove immediately, document in log
Storage & Calibration
  • Always hang on dedicated rack — never fold (creates cracks)
  • Annual dose calibration by qualified medical physicist
  • Miscalibrated unit may under-report dose — high-dose cases may have exceeded SRDL without triggering notification
Quick Recall — Image Production
  • 5 Gy Ka,r → SRDL notification threshold (NCRP 168)
  • 15 Gy PSD → TJC sentinel event threshold
  • Smaller FOV = MORE dose (AEC paradox)
  • LIH = ZERO radiation (holds last frame)
  • Tube above table = scatter DOWN = safer for staff
  • DSA misregistration = patient movement (not injection rate)
  • D5W ONLY for RFA hydrodissection (not NS)
  • Maximum SID = less dose (inverse square law)
42 Questions · 26% of Exam
Vascular Diagnostic

The largest content area. Vascular diagnostic tests access techniques, catheter selection, anatomy, projections, and IVC anatomy for filter placement. Know your projections cold — they’re tested constantly.

Why High-Yield

26% of the exam. Master the projections (LAO 45° for aortic arch, lateral for celiac/SMA, LPO for right renal, RPO for left renal), know the Seldinger technique cold, and understand IVC anatomy variants. Femoral access details and catheter selection are tested heavily.

Vascular Access — Femoral Technique
Femoral Artery Access
  • Target: common femoral artery over the medial femoral head
  • Femoral head = backstop for compression post-procedure
  • Too high (above inguinal lig.) → retroperitoneal hematoma
  • Too low (below bifurcation) → pseudoaneurysm, AV fistula
  • Fluoroscopic landmark: inferior border of femoral head
  • Seldinger: needle → wire → dilator → sheath
Access Complications
  • Hematoma — most common complication
  • Pseudoaneurysm — pulsatile mass, visible on US
  • AV fistula — continuous bruit, venous pulsations
  • Retroperitoneal bleed — high stick, flank pain, ↓Hgb
  • Arterial dissection — resistance to wire
  • Vasovagal — bradycardia + hypotension post-procedure
Key Projections — Must Memorize
Vessel/StudyBest ProjectionWhy
Aortic archLAO 45°Opens arch, shows origins of great vessels
Celiac axisLateralShows origin off aorta without overlap
SMALateralSame as celiac; anterolateral origin
Right renal arteryLPOOpens right renal origin off aorta
Left renal arteryRPOOpens left renal origin off aorta
Carotid bifurcationLAO 45° + cranialSeparates ICA from ECA
Renal hilumIpsilateral posterior obliqueShows bifurcation pattern
Adrenal vein samplingRight = technically difficultShort right adrenal vein drains directly to IVC
IVC Anatomy Variants — Critical for Filter Placement
VariantPrevalenceImpact on Filter Placement
Duplicated IVC<1%Bilateral iliac filters OR suprarenal single filter
Circumaortic left renal vein3–4%Must image both limbs; filter above highest LRV
Retroaortic left renal vein2–3%Filter below LRV insertion to avoid thrombosis
Left-sided IVC<0.5%Crosses midline; access may require repositioning
Cavagram rule: Mandatory before EVERY IVC filter placement regardless of prior imaging. Anatomy can change. Thrombus may extend higher than expected.

Standard filter position: Infrarenal IVC just below the lowest renal vein. Suprarenal placement only when infrarenal is not possible (e.g., thrombus up to renals, pregnancy, duplicated IVC).

Catheter Selection
CatheterShape/UseKey Application
Cobra (C2)Simple curveCeliac, SMA, renal arteries from femoral
Simmons (SIM)Reverse curveDifficult arch anatomy; subclavian, carotid from femoral
Headhunter (H1)Angled tipGreat vessel selection from femoral approach
PigtailCurled tip, multiple side holesAortogram, ventriculogram (high flow)
BernsteinSlight angleSelective vessel catheterization, brachial approach
KumpeAngled tipSelective catheterization, drainage
Exam Traps — Vascular Diagnostic
  • Trap: Celiac/SMA best seen in AP FALSE. Lateral projection shows celiac and SMA origin off the anterior aorta.
  • Trap: Duplicated IVC is common (>5%) FALSE. Prevalence is <1%. Circumaortic LRV is 3–4%.
  • Trap: Cavagram can be skipped if recent CT shows normal IVC FALSE. Mandatory before every filter placement.
  • Trap: Right adrenal vein sampling is straightforward FALSE. It’s technically difficult due to the short right adrenal vein draining directly to the IVC.
  • Trap: Femoral head is a landmark for arterial compression, not needle entry FALSE. The femoral head is the backstop for BOTH needle entry and post-procedural compression.
  • Trap: LAO 45° is used for renal arteries FALSE. LAO 45° = aortic arch. Renal arteries use LPO (right) and RPO (left).
Clinical Scenarios
Scenario 1

Cavagram before IVC filter placement shows two IVC channels from L4 to the confluence. What are your filter options?

Answer

Duplicated IVC (<1% prevalence). Options: bilateral common iliac filters OR single suprarenal filter above the duplication.

Scenario 2

Physician asks for best projection to visualize the celiac axis takeoff during an aortogram. What do you set up?

Answer

Lateral projection. The celiac and SMA originate from the anterior aorta — lateral view shows these origins without vessel overlap.

Scenario 3

Post-femoral arterial puncture, patient has a pulsatile groin mass with a bruit. What complication and what diagnostic test?

Answer

Pseudoaneurysm. Diagnose with duplex ultrasound. Treat with ultrasound-guided compression or thrombin injection.

Scenario 4

During right renal arteriogram, the origin of the right renal artery is not well visualized in AP. What projection do you try?

Answer

LPO (left posterior oblique). This rotates the aorta to open the right renal artery origin.

Central Venous Device Check

Performed for malfunctioning central venous devices: no blood return, poor flow, difficult infusion.

FindingFluoroscopic AppearanceManagement
Fibrin sheathContrast outlines outside of catheter and flows back up tractAlteplase (tPA) dwell: 2 mg in 2 mL, 30–120 min, then aspirate
Tip malpositionTip in IJ, axillary, or azygos vein — not in SVCReposition over guidewire
Intraluminal thrombusFilling defect within catheter lumentPA dwell; consider exchange if failed
Catheter fractureContrast leak at fracture siteRemove catheter; foreign body retrieval if fragment embolized
Pinch-off syndromeCatheter kinked at costoclavicular spaceRemove before complete fracture and embolization
Ideal Catheter Tip Positions
  • PICC/Port: lower SVC or SVC–RA junction
  • Too high (above right clavicle): malposition → reposition
  • Right atrium: arrhythmia risk → pull back
  • Right ventricle: urgent repositioning — perforation risk
Port Access
  • Access only with non-coring Huber needle (right-angle bent tip)
  • Resistance + pain at port site → stop; assess for needle malposition before any injection
  • Ports sustain 1,000–3,500+ access cycles depending on model
Lymphangiography
Indications
  • Chylous leak (chylothorax, chylous ascites) — pre-thoracic duct embolization mapping
  • Chylothorax clue: milky pleural fluid, triglycerides >110 mg/dL
Technique & Key Facts
  • Contrast: Lipiodol (ethiodized oil) — oil-based; persists in nodes for months
  • Intranodal approach (preferred): ultrasound-guided direct inguinal node puncture
  • Cisterna chyli: L1–L2; thoracic duct drains to left subclavian–jugular junction
  • Thoracic duct embolization (TDE): coils ± NBCA; ~70–80% success
Exam Trap: Lipiodol is oil-based — NOT standard iodinated aqueous contrast. Do not confuse them.
Vascular Anatomy — Aorta & Celiac Territory
Abdominal Aortic Branches (T12–L5)
BranchLevel
Celiac trunkT12–L1
Superior mesenteric artery (SMA)L1
Renal arteries (bilateral)L1–L2
Inferior mesenteric artery (IMA)L3
Aortic bifurcation → common iliacL4
Celiac Trunk Trifurcation
  • Left gastric artery — smallest; supplies lesser curvature of stomach
  • Splenic artery — largest and most tortuous; runs along superior pancreatic border
  • Common hepatic artery — gives off GDA then becomes proper hepatic artery → divides into right and left hepatic arteries
  • Classic trifurcation present in ~89% of individuals
Exam Trap: The gastroduodenal artery (GDA) passes POSTERIOR to the first part of the duodenum. Posterior duodenal ulcers erode the GDA — the classical cause of massive upper GI hemorrhage treated by GDA coil embolization.
Hepatic Arterial Variants — Michels Classification

Hepatic arterial anatomy is highly variable. Every patient undergoing TACE or hepatic embolization requires complete mapping before treatment.

VariantPrevalenceClinical Impact
Replaced RHA from SMA10–15%Most common variant — absent right hepatic on celiac arteriogram → catheterize SMA
Replaced LHA from left gastric~10%Second most common — runs in lesser omentum → superselect left gastric
Accessory RHA from SMA~7%Additional right hepatic supply alongside normal RHA — both must be embolized
Michels Type IX (replaced CHA from SMA)RareEntire liver supplied by SMA — no hepatic branches visible on celiac arteriogram
Normal (Type I)~55%Celiac gives off all three vessels; standard hepatic supply
Critical: Before any hepatic embolization — perform celiac arteriogram FIRST, then SMA arteriogram to identify replaced/accessory hepatic vessels. Missing a replaced hepatic artery = incomplete treatment or non-target embolization.
IVC Anatomy & Variants — Critical for Filter Placement
Normal IVC Anatomy
  • Forms at L4–L5 from junction of common iliac veins
  • Ascends on the RIGHT side of aorta
  • Receives renal veins at L1–L2, hepatic veins at T8–T9
  • Passes through caval hiatus of diaphragm at T8
  • Standard filter placement: infrarenal (below renal veins)
IVC Variants — Alter Filter Strategy
  • Duplicated IVC (0.2–3%) — bilateral infrarenal filters OR suprarenal filter above confluence
  • Left-sided IVC (0.2–0.5%) — joins left renal vein → crosses anterior to aorta; filter in left-sided IVC via left femoral access
  • Circumaortic LRV (2.4–8.7%) — two left renal veins encircle aorta; retro-aortic limb may be lower — may need suprarenal filter
  • Retro-aortic LRV (~3%) — single left renal vein crosses posterior to aorta
Cavogram Tip: Duplicated IVC suspected when left common iliac vein inflow defect is absent on right femoral cavogram and infrarenal IVC appears smaller than expected.
Portal Venous System & Mesenteric Collaterals
Portal System Formation
  • Portal vein = SMV + splenic vein, posterior to pancreatic neck at L1–L2
  • IMV drains into splenic vein (NOT directly into portal confluence)
  • Portal vein ascends in hepatoduodenal ligament with hepatic artery (left) and bile duct (right)
  • Divides at porta hepatis into right and left portal veins
Key Mesenteric Collaterals
  • Arc of Riolan — middle colic (SMA) → left colic (IMA); central mesentery; prominent in SMA/IMA occlusion
  • Marginal artery of Drummond — runs along inner colon margin; connects SMA and IMA territories
  • Pancreaticoduodenal arcade — connects celiac and SMA; preserved if either is occluded
Renal & Adrenal Venous Anatomy
StructureLeft SideRight Side
Renal vein lengthLonger — crosses anterior to aortaShort — drains directly into IVC
TributariesLeft gonadal + left adrenal + left phrenicNone — right gonadal and adrenal drain directly into IVC
Adrenal veinDrains into left renal veinDrains directly into right IVC posterolateral wall (3–5mm) — most challenging AVS catheterization
Gonadal veinLeft gonadal → left renal vein (varicocele/PCS embolization via left renal vein)Right gonadal → directly into IVC
Nutcracker Syndrome: Left renal vein compressed between abdominal aorta and SMA → left renal venous hypertension → hematuria, left flank pain, left varicocele/pelvic congestion. Treatment: LRV stenting or transposition.
Cerebrovascular Anatomy — Arch to Circle of Willis
Aortic Arch Branches (Proximal to Distal)
  1. Brachiocephalic (innominate) trunk — divides into right common carotid + right subclavian
  2. Left common carotid artery
  3. Left subclavian artery

Left vertebral artery arises directly from arch in ~6% (between left CCA and left subclavian).

Circle of Willis Connections
  • AComm (anterior communicating) — bridges L and R anterior circulations (ACAs) — most common aneurysm site (30–35%)
  • PComm (posterior communicating) — bridges ICA to PCA bilaterally
  • Vertebral arteries arise from subclavian arteries → unite at pontomedullary junction → basilar artery → bilateral PCAs
  • Left vertebral dominant ~45%; right dominant ~30%; co-dominant ~25%
CCA Bifurcation (Key for Carotid Stenting)
  • Bifurcates at C3–C4 (upper thyroid cartilage level)
  • ICA — larger, posterior/lateral; NO branches in the neck
  • ECA — smaller, anterior/medial; multiple neck branches
  • Carotid body (chemoreceptor) + carotid sinus (baroreceptor) at bifurcation
ARRT Exam Focus
  • Aortic arch anatomy required for catheter selection in neuro cases
  • Bovine arch (common origin CCA + brachiocephalic) — ~7% of population
  • Vertebral artery anomalies affect access for vertebral angiography
  • Know Mani vs Simmons catheter for difficult aortic arch configurations
Peripheral Arterial Anatomy — Lower Extremity Runoff
VesselLocation / CourseKey Clinical Point
Common femoral artery (CFA)Overlies medial third of femoral headStandard access site; target puncture over femoral head for hemostasis
Profunda femorisArises from CFA 3–5cm below inguinal ligamentCollateral source in SFA occlusion; not a target for angioplasty
Superficial femoral artery (SFA)Passes through adductor (Hunter's) canalMost common site of PAD; transitions to popliteal at adductor hiatus
Popliteal arteryPosterior to knee in popliteal fossaDivides at lower popliteal fossa into AT and tibioperoneal trunk
Anterior tibial arteryPasses through interosseous membrane anteriorlyContinues as dorsalis pedis at foot
Tibioperoneal trunkShort segment after AT takeoffDivides into posterior tibial (medial) and peroneal (lateral/fibular)
Posterior tibial arteryMedial calf behind medial malleolusSupplies plantar foot; palpable posterior to medial malleolus
Peroneal arteryLateral compartment alongside fibulaOften last patent vessel in critical limb ischemia — may be only outflow
Pelvic Projections: 25° RAO profiles the LEFT internal iliac system; 25° LAO profiles the RIGHT — counterintuitive but high-yield ARRT question.
Quick Recall — Vascular Diagnostic
  • Aortic arch → LAO 45°
  • Celiac & SMA → Lateral
  • Right renal → LPO  |  Left renal → RPO
  • Femoral head = backstop for compression AND needle entry landmark
  • Cavagram mandatory before EVERY IVC filter (no exceptions)
  • Duplicated IVC <1% → bilateral iliac filters or suprarenal
  • Circumaortic LRV 3–4%  |  Retroaortic LRV 2–3%
  • Right adrenal vein = technically difficult (short, directly to IVC)
42 Questions · 26% of Exam
Vascular Interventional

The most procedure-heavy section. TIPS, IVC filters, embolization, CDT, Y-90, and ablation. Know your PSG targets, embolization agent properties, and CDT contraindications cold.

Why High-Yield

This section rewards techs who understand procedure rationale, not just steps. Know why TIPS targets PSG <12 mmHg, why Gelfoam is temporary, why D5W is used for RFA, and why MWA has no heat-sink effect. These are the distinctions that separate passing from failing.

TIPS — Transjugular Intrahepatic Portosystemic Shunt
ParameterValueNotes
PSG target (all indications)<12 mmHgAASLD 2021; applies to varices AND refractory ascites
Optimal PSG<8–10 mmHgBetter variceal bleed control
Standard stentVIATORR (ePTFE-covered)Reduces pseudointimal hyperplasia vs bare metal
Most common delayed complicationHepatic encephalopathy25–35% of patients; ammonia elevation
Access veinRight hepatic vein → right portal veinMost common approach
Absolute CISevere right heart failure, polycystic liver, uncontrolled sepsisRelative CI: moderate encephalopathy
PSG math: Portal pressure minus hepatic wedge pressure. If PSG ≥12 mmHg before TIPS = varices likely re-bleed. Goal after TIPS = <12 mmHg.
Embolization Agents — Properties
AgentDurationPrimary UseKey Fact
GelfoamTemporary (days–weeks)Trauma, GI bleed, post-partum hemorrhageResorbs; vessel recanalizes
CoilsPermanentAneurysms, AVMs, vessel occlusionMechanical occlusion; platinum or stainless
PVA particlesPermanentUAE, tumor embolizationSize selection determines level of occlusion
EmbospheresPermanentUAE, HCC, tumorCalibrated microspheres; more uniform than PVA
Onyx (EVOH)PermanentAVM, aneurysmLiquid agent; requires DMSO-compatible microcatheter
n-BCA gluePermanentRapid hemorrhage, AVFPolymerizes on contact with blood; fast set
Ethanol (EtOH)PermanentRenal ablation, AVM sclerosisCytotoxic; extreme pain — general anesthesia
CDT — Catheter-Directed Thrombolysis
CDT Protocol
  • Drug: alteplase (tPA) — 0.5–1 mg/hr intra-catheter
  • Concurrent UFH: 300–500 units/hr (systemic anticoagulation)
  • Check fibrinogen q8h — stop if <150 mg/dL
  • Neurological checks q1h during infusion
  • Post-CDT: angioplasty/stent for underlying stenosis
CDT Contraindications
  • Absolute: Active intracranial hemorrhage
  • Absolute: Stroke <2 months (ischemic OR hemorrhagic)
  • Absolute: Active internal bleeding
  • Absolute: Recent (<2 months) intracranial/spinal surgery
  • Relative: Recent surgery <10 days, pregnancy, severe hypertension
Y-90 Radioembolization
ParameterValue/Details
IsotopeYttrium-90 (Y-90) — pure beta emitter
Pre-procedure imagingTc-99m MAA scan (mandatory) — assesses lung shunt fraction
Lung shunt CI>20% lung shunt fraction = contraindication
GI shunting concernAberrant vessels to bowel = risk of radiation gastroenteritis
Main indicationUnresectable HCC, colorectal liver mets
Post-embolization syndromeFever, nausea, fatigue — expected; manage supportively
Tc-99m MAA rule: Always required before Y-90. If lung shunt >20%, do NOT proceed. No exceptions.
Ablation — RFA vs MWA
FeatureRFA (Radiofrequency)MWA (Microwave)
MechanismIonic agitation → heatWater molecule oscillation → heat
Heat-sink effectYes — vessels >3mm reduce ablation zoneNo — not limited by adjacent vessels
Hydrodissection fluidD5W ONLY (electrically inert)D5W preferred but less critical
SpeedSlowerFaster (higher temps achieved)
Tumors near vesselsSuboptimal (heat-sink)Preferred
Exam Traps — Vascular Interventional
  • Trap: TIPS PSG target is <8 mmHg PARTIAL. <12 mmHg is the standard target per AASLD 2021 for ALL indications. Optimal is <8–10 mmHg but <12 is what’s tested.
  • Trap: Gelfoam is a permanent embolic agent FALSE. Gelfoam is temporary; recanalizes within days to weeks.
  • Trap: MWA has a heat-sink effect near vessels FALSE. MWA is NOT affected by heat-sink. RFA is.
  • Trap: CDT with tPA is safe 3 months post-stroke FALSE. Stroke <2 months is an absolute contraindication.
  • Trap: Y-90 Tc-99m MAA scan is optional if CT looks clean FALSE. Mandatory. Lung shunt fraction >20% = absolute contraindication.
  • Trap: TIPS encephalopathy rate is <10% FALSE. 25–35% of patients develop hepatic encephalopathy post-TIPS.
Clinical Scenarios
Scenario 1

Post-TIPS, portal pressure is 18 mmHg and hepatic wedge is 9 mmHg. Is the procedure successful?

Answer

PSG = 18 − 9 = 9 mmHg. Yes — this is <12 mmHg. Procedure successful per AASLD criteria.

Scenario 2

Pre-Y-90 Tc-99m MAA scan shows 22% lung shunt fraction. What do you do?

Answer

Do NOT proceed. Lung shunt >20% is an absolute contraindication to Y-90 radioembolization. Radiation pneumonitis risk is too high.

Scenario 3

During RFA of a 3.5cm renal tumor adjacent to the renal vein, ablation zones are consistently smaller than expected. Why?

Answer

Heat-sink effect. The adjacent large vessel (renal vein) dissipates heat, reducing the effective ablation zone. Consider MWA instead.

Scenario 4

Patient had ischemic stroke 6 weeks ago and now has acute iliofemoral DVT with phlegmasia. Can you perform CDT?

Answer

No. Stroke <2 months is an absolute contraindication to CDT. The risk of intracranial hemorrhage is too high.

Atherectomy — Four Types
TypeDevice ExampleMechanismKey Fact
DirectionalSilverHawk, TurboHawkRotating cutter shaves plaque; collected in nosecone for removalDebris removed from body in nosecone
RotationalRotablatorDiamond burr at high speed; microparticles <7μm pass distallyDebris embolizes distally to lungs
OrbitalDiamondback 360Eccentric diamond crown; larger zone at higher speedBidirectional; one crown size treats multiple vessel diameters
Laser (Excimer)Turbo-Elite308 nm UV photons break molecular bonds (no heat)CTO, in-stent restenosis, thrombus
Exam Trap: Rotational atherectomy debris goes distally (absorbed by lungs). Directional atherectomy debris is collected in the nosecone and removed. This distinction is tested.

No-reflow after rotational atherectomy: treat with intracoronary vasodilators (adenosine, nitroprusside, or verapamil) — NOT stenting.

Endograft Placement — EVAR & TEVAR
EVAR (Abdominal)
  • Indications: AAA ≥5.5 cm (men), ≥5.0 cm (women), or rapidly enlarging (>0.5 cm/6 mo)
  • Requires: infrarenal neck ≥10–15 mm, angulation <60°, iliac access ≥7 mm
  • Post-EVAR follow-up: CTA at 1 month, 12 months, then annually
TEVAR (Thoracic)
  • Indications: descending TAA ≥5.5–6 cm, traumatic transection (zone 3–4), complicated type B dissection
  • Spinal cord ischemia = most feared complication — coverage of T8–L2 intercostals
  • Prevention: CSF drainage + maintain MAP >80–85 mmHg
Endoleak Types
TypeSourceManagement
Type ISeal failure at landing zone (Ia proximal, Ib distal)Urgent repair — highest rupture risk
Type IIBranch vessels (IMA, lumbar) filling sac retrogradelyObserve if sac stable; embolize if sac grows
Type IIIGraft defect or junction separationUrgent repair
Type IVGraft porosity (rare with modern grafts)Usually self-limited
Transvenous (Transjugular) Liver Biopsy
Indications (vs. Percutaneous)
  • Coagulopathy (INR >1.5–2.0) — bleeding tracks into hepatic vein, not peritoneum
  • Tense ascites — avoids hepatic capsule traversal
  • Thrombocytopenia (platelets <50,000)
  • Simultaneous HVPG measurement desired
HVPG Measurement
  • HVPG = Wedged HVP − Free HVP
  • Normal: 1–5 mmHg
  • >10 mmHg = clinically significant portal HTN
  • >12 mmHg = variceal hemorrhage risk
  • TIPS target: <12 mmHg (AASLD 2021)
Complication to know: Hemobilia — hepatic artery to biliary fistula → Quincke’s triad: RUQ pain + jaundice + GI bleeding (delayed 1–5 days). Treatment: hepatic artery embolization.

Adequate biopsy: minimum 6 portal tracts; 11 recommended for reliable fibrosis staging.

Distal Protection Devices
TypeMechanismExamples
Filter wireMicropore basket captures debris distal to lesion; retrieved after stentSpiderFX, Emboshield NAV6, FilterWire EZ
Proximal occlusionBalloons in ECA + CCA create no-flow field; debris aspirated before restoring flowMo.Ma Ultra
Mandatory for carotid artery stenting (CAS) — Class I recommendation. Filter deployed in disease-free distal ICA; retrieved with dedicated catheter after stent + post-dilation. This is a tested ARRT topic.
Foreign Body Retrieval
Common Foreign Bodies
  • Fractured guidewires (most common)
  • Broken port catheter fragments (pinch-off syndrome)
  • Embolized IVC filter struts
  • Misdeployed coils
Retrieval Devices
  • Gooseneck snare (Amplatz): most common; 90° loop lassoes object
  • En Snare: three-loop design for irregular objects
  • Alligator forceps: jaw-style grasper for right heart objects
Critical technique: Object is snared and pulled INTO a large sheath before extraction — never pulled directly through vessel wall. Sheath must accommodate the object.

Pinch-off syndrome: port catheter compressed between clavicle and 1st rib → fracture → fragment lodges in RV or PA. Recognized by >90° catheter angle at costoclavicular space on fluoroscopy.

Hybrid OR — Interventional Suite vs. Hybrid Operating Room
FeatureIR SuiteHybrid OR
ImagingFixed angiography systemSame + CBCT, fusion imaging capability
Surgical capabilityMinor open access onlyFull open surgery: anesthesia boom, surgical lighting, instrument tables
TeamIR tech, interventionalist, RNAll of above + surgeon, anesthesiologist, scrub tech
Key advantageIn-room surgical conversion without patient transport
Room size~480–600 sq ft~750–1,100 sq ft
Why it matters on the exam: EVAR/TEVAR failure → immediate surgical conversion in same room. Fixed flat-panel detectors → superior image quality at lower dose vs. mobile C-arm. Added to ARRT spec in 2022 update.
Procedural Anatomy — Key Relationships for Interventions
Uterine Artery Embolization (UAE)
  • Uterine artery — first major branch of anterior division of internal iliac
  • Crosses superior to the ureter (“water under the bridge”)
  • Ovarian artery arises directly from aorta — separate supply to uterine fundus
  • Non-target embolization of ovarian artery → premature ovarian failure
Artery of Adamkiewicz — TEVAR Risk
  • Dominant anterior spinal artery feeder to thoracolumbar cord
  • Arises from left intercostal/lumbar artery between T8–L1 in ~75%
  • Left-sided in ~80% of individuals
  • TEVAR coverage of this level → spinal cord ischemia (paraplegia)
  • Prevention: CSF drainage + MAP >80–85 mmHg
Hepatic Dome HCC Parasitic Supply
  • Right inferior phrenic artery (IPA) — most common extrahepatic feeder for HCC in segments VII/VIII (hepatic dome)
  • Occurs in ~10–15% of HCC cases — must catheterize separately for complete TACE
  • Other feeders: intercostal arteries, right internal mammary, omental vessels
TIPS Anatomy
  • Access via right hepatic vein (most common) from right IJV
  • Needle directed anteriorly, inferiorly, medially toward right portal vein
  • HVPG measured: WHVP − FHVP
  • Normal HVPG: 1–5 mmHg; >10 = clinically significant PHT; >12 = variceal risk
  • TIPS target: <12 mmHg (AASLD 2021)
Quick Recall — Vascular Interventional
  • TIPS PSG target: <12 mmHg (AASLD 2021) — ALL indications
  • TIPS most common delayed complication: hepatic encephalopathy (25–35%)
  • Gelfoam = temporary  |  Coils/PVA/Onyx = permanent
  • CDT alteplase dose: 0.5–1 mg/hr intra-catheter
  • CDT absolute CI: stroke <2 months
  • Y-90 pre-procedure: Tc-99m MAA mandatory — lung shunt >20% = stop
  • RFA: heat-sink effect near vessels  |  MWA: no heat-sink
  • D5W ONLY for RFA hydrodissection — never NS
28 Questions · 18% of Exam
Nonvascular

Nonvascular covers the breadth of IR: nephrostomy, biliary drainage, biopsy, spine procedures, and drainage. Know your access points, cement properties, and why urosepsis is the most dangerous nonvascular complication.

Why High-Yield

The exam tests nephrostomy access anatomy (posterior lower pole calyx), biliary drainage hierarchy, vertebroplasty vs kyphoplasty distinctions, and complication management. Biopsy needle types and yield are also frequently tested. Urosepsis as the #1 life-threatening nonvascular complication appears on almost every exam.

Percutaneous Nephrostomy — Access Anatomy
Optimal Access
  • Target: posterior lower pole calyx
  • Approach: Brödel’s avascular line (lateral avascular plane)
  • Posterior calyces point posterolaterally → most accessible
  • Needle passes through renal parenchyma into collecting system
  • Fluoroscopy + ultrasound guidance for initial access
Upper Pole Risks
  • Upper pole access → risk of pneumothorax (above 12th rib)
  • Also: pleural effusion, hydrothorax
  • Avoid if possible; use subcostal approach
  • If upper pole required: expiration approach, confirm with CXR post-procedure
ComplicationTypeNotes
UrosepsisMost dangerousCan be fatal; antibiotics BEFORE procedure mandatory
Perinephric hematomaMost commonUsually self-limiting; watch Hgb
PneumothoraxUpper pole accessCXR after any above-12th-rib access
Injury to adjacent organsColon, spleenPre-procedure CT to assess anatomy
Biliary Drainage — PTC & PTBD
Procedure Hierarchy
  • PTC (cholangiogram) — diagnostic only; delineates biliary anatomy
  • PTBD (biliary drain) — therapeutic; external or internal-external
  • External drain — above obstruction only; bile drains to bag
  • Internal-external — crosses obstruction; bile into duodenum + bag
  • Fully internalized (stent) — no external drain; bile drains internally only
Key Safety Rules
  • Antibiotics BEFORE biliary procedure — infected bile = immediate sepsis risk
  • Right-sided access: right midaxillary line, 8th–9th intercostal space
  • Left-sided access: subxiphoid/epigastric approach
  • Cholangiography: contrast fills system; identify level of obstruction
Vertebroplasty vs Kyphoplasty
FeatureVertebroplastyKyphoplasty
MechanismPMMA cement injected directly into fractureBalloon tamp inserted first → cavity created → cement
Height restorationMinimal to nonePossible (balloon expands before cement)
Cement volumeHigher (no cavity)Lower (fills cavity)
Cement leak riskHigherLower (cavity contains cement)
CostLowerHigher
IndicationPainful osteoporotic VCF, myelomaSame; preferred when height restoration desired
Critical safety rule: Cement leak into the epidural space → STOP injection immediately + neurological check. Epidural cement = potential cord compression.

PMMA (polymethylmethacrylate) = bone cement used in both procedures. Viscosity matters: too thin → leaks; too thick → won’t flow.

Biopsy — Needles & Yield
TypeNeedleSampleBest For
Fine needle aspiration (FNA)20–25G cutting/aspirationCytology (cells)Thyroid, lymph nodes, cysts
Core needle biopsy14–18G spring-loadedHistology (tissue architecture)Liver, lung, renal, soft tissue
Coaxial techniqueIntroducer + inner needleMultiple samples, one passReduces tract seeding risk
Vacuum-assisted8–11G rotationalLarger samplesBreast, bone marrow

Lung biopsy specific: Most common complication = pneumothorax. Occurs in 20–35% but only ~5% require chest tube. Moderate bleeding risk (INR <1.5 required).

Exam Traps — Nonvascular
  • Trap: Upper pole nephrostomy is the preferred access FALSE. Posterior lower pole calyx is standard. Upper pole = pneumothorax risk.
  • Trap: Kyphoplasty always restores vertebral height FALSE. Height restoration is possible, not guaranteed. Depends on fracture acuity.
  • Trap: Vertebroplasty has lower cement leak risk than kyphoplasty FALSE. Vertebroplasty injects directly — higher leak risk. Kyphoplasty fills a pre-formed cavity.
  • Trap: Perinephric hematoma is the most dangerous nephrostomy complication FALSE. Most common yes, but most dangerous = urosepsis (can be fatal).
  • Trap: Biliary procedures don’t require pre-procedure antibiotics if patient is afebrile FALSE. All biliary procedures require antibiotics BEFORE starting, regardless of fever status.
  • Trap: FNA provides tissue architecture for histology FALSE. FNA = cytology only. Core needle biopsy = histology (tissue architecture).
Clinical Scenarios
Scenario 1

During PTBD, patient becomes febrile and hypotensive immediately after bile is aspirated. What is happening and what do you do?

Answer

Urosepsis/biliary sepsis from infected bile entry into bloodstream. Broad-spectrum antibiotics immediately, IV fluids, blood cultures, and expedite drainage. This is life-threatening.

Scenario 2

During kyphoplasty cement injection, the patient reports sudden new back pain. Fluoroscopy shows cement tracking toward the posterior cortex. What do you do?

Answer

Stop injection immediately. Assess for epidural leak. Neurological check. Epidural cement can cause cord compression — this is a surgical emergency if neurological deficits develop.

Scenario 3

Nephrolithiasis patient needs nephrostomy drainage above the 11th rib due to anatomy. Post-procedure, patient is dyspneic. First test?

Answer

Chest X-ray to rule out pneumothorax. Upper pole/intercostal access carries risk of pneumothorax. May require chest tube if large.

Scenario 4

Pathology requests tissue architecture for suspected hepatocellular carcinoma. Which biopsy needle type do you use?

Answer

Core needle biopsy (14–18G spring-loaded). FNA provides cytology only — insufficient for tissue architecture/histology required for HCC diagnosis.

Suprapubic Catheter Placement
  • Indications: urinary retention not amenable to urethral catheterization (stricture, trauma, false passage); long-term bladder drainage
  • Critical requirement: bladder must be adequately distended (>300 mL) — confirmed by ultrasound before puncture
  • Access: midline suprapubic, 2–3 cm above pubic symphysis; ultrasound + fluoroscopy guidance
  • Confirm with contrast injection — fills bladder lumen, no perivesical extravasation
  • First exchange: wait 2–4 weeks for tract maturation; routine exchange every 4–8 weeks
Antegrade Urography & Whitaker Test
Antegrade Urography
  • Contrast injected through existing nephrostomy tube
  • Assesses: collecting system, ureteral obstruction location, stricture, leak, passage to bladder
Whitaker Test (Pressure-Perfusion)
  • Differentiates obstructed vs. non-obstructed dilated system
  • Saline perfused at 10 mL/min; renal pelvis pressure measured simultaneously
  • Normal: <15 cmH&sub2;O
  • Obstructed: >22 cmH&sub2;O
  • Equivocal: 15–22 cmH&sub2;O
Enteric Tube Evaluation (G-tube / GJ-tube Verification)
  • Inject water-soluble contrast (Gastrografin / diatrizoate — NOT barium) through tube under fluoroscopy
  • Contrast fills stomach = G-tube correct; passes to jejunum = GJ-tube correct
  • Extravasation into peritoneum = tube dislodged → STOP feeds immediately
  • Barium is contraindicated — peritoneal barium causes chemical peritonitis
Cholecystostomy
Indications
  • Acute cholecystitis in patients too high-risk for surgery (elderly, critically ill)
  • Acalculous cholecystitis in ICU patients
  • Bridge to surgical cholecystectomy
Technique
  • Transhepatic approach preferred — liver provides tamponade layer, reduces bile leak vs. transperitoneal
  • Ultrasound guidance; locking drainage catheter placed into gallbladder
  • Confirm with contrast injection — fills gallbladder, no extravasation
  • Catheter matured 4–6 weeks before cystogram or stone extraction
Exam Trap: Preferred access is transhepatic, not transperitoneal. The liver acts as a tamponade reducing bile leak risk.
Tunneled Drainage Catheters (PleurX)
PleurX (Tunneled Pleural)
  • Indication: recurrent malignant or refractory pleural effusion
  • 15.5 Fr catheter tunneled from pleural entry to skin exit site
  • Drained at home via vacuum bottles 3×/week
  • Spontaneous pleurodesis in ~40–50% of malignant cases
  • Proprietary one-way valve — requires specific drainage kit; standard syringes cannot connect
Peritoneal Tunneled Drain
  • Indication: recurrent malignant ascites
  • Same tunneling technique as PleurX
  • Allows outpatient drainage without repeated paracentesis
Lumbar Puncture & Myelogram
Lumbar Puncture
  • Entry level: L3–L4 or L4–L5 (below conus medullaris at L1–L2)
  • Preferred needle: 22–25G pencil-point (Sprotte or Whitacre) → reduces post-LP headache
  • Normal opening pressure: 7–18 cmH&sub2;O (lateral decubitus)
  • Post-LP headache (10–30%): supine, fluids, caffeine; blood patch if severe
Myelogram — Critical Safety
  • Contrast: Iohexol (Omnipaque) ONLY — nonionic water-soluble, intrathecally approved
  • NEVER: ionic contrast (seizures), gadolinium (not standard of care), barium (absolute CI)
  • Post-procedure: keep patient upright 30–45° for 4–6 hours
  • Post-myelogram CT within 60 minutes
Epidural Steroid Injection (ESI)
ApproachBest ForNotes
Transforaminal (TFESI)Unilateral radiculopathy; targetedMost common in IR; “Scotty dog” oblique view; inject to safe triangle
Interlaminar (ILESI)Central/bilateral symptomsBroad spread; between laminae
CaudalL5–S1 predominant; prior surgeryVia sacral hiatus
CRITICAL SAFETY RULE: For cervical transforaminal ESI — use dexamethasone ONLY (non-particulate). Triamcinolone or methylprednisolone (particulate steroids) can embolize to the vertebral or anterior spinal artery → cord infarction / stroke. This is a high-stakes ARRT exam topic.
Paracentesis — SIR Risk & Albumin Replacement
SIR Bleeding Risk Classification
  • Paracentesis = LOW risk — same as thoracentesis
  • No specific INR or platelet correction threshold required
  • Coagulation parameters do not reliably predict bleeding for low-risk procedures
Albumin Replacement (LVP >5 L)
  • Prevents paracentesis-induced circulatory dysfunction (PICD)
  • IV albumin: 6–8 g per liter removed, given after procedure
  • Normal saline is NOT an acceptable substitute
  • Volumes <5 L: albumin not required
Exam Trap: Candidates assume coagulopathy requires correction before paracentesis — SIR guidance does NOT support routine correction for this LOW-risk procedure.
Procedural Anatomy — Nonvascular Access
Nephrostomy Access Anatomy
  • Target: posterior lower pole calyx via posterolateral approach
  • Access through posterior axillary line — avoids descending colon anteriorly
  • Needle directed in axis of infundibulum toward calyx
  • Upper pole access reserved for ureteropelvic junction obstruction or complex stone work
  • Collecting system accessed under fluoroscopic + ultrasound guidance
Biliary Anatomy
  • Right + Left hepatic ducts → common hepatic duct at porta hepatis
  • Cystic duct joins CHD → forms common bile duct (CBD)
  • CBD descends in hepatoduodenal ligament (with portal vein posterior, hepatic artery left)
  • CBD traverses pancreatic head → drains at ampulla of Vater into D2
  • PTC/PTBD: right or left intrahepatic approach targeting peripheral ducts
Lumbar Puncture Layers (L3–L4 or L4–L5)
  1. Skin → subcutaneous fat
  2. Supraspinous ligament
  3. Interspinous ligament
  4. Ligamentum flavum (“pop” felt here)
  5. Epidural space
  6. Dura mater → arachnoid → subarachnoid space (CSF)
Vertebroplasty Access
  • Transpedicular approach — needle through pedicle into posterior vertebral body
  • Critical boundary: medial pedicle wall must not be violated → spinal canal
  • Lateral wall violation → pneumothorax (thoracic) or retroperitoneal injury (lumbar)
  • Cement must NOT cross posterior vertebral cortex
Quick Recall — Nonvascular
  • Nephrostomy access: posterior lower pole calyx via Brödel’s line
  • Upper pole access → pneumothorax risk (post-CXR mandatory)
  • Most dangerous nephrostomy complication: urosepsis (can be fatal)
  • Most common nephrostomy complication: perinephric hematoma
  • Biliary procedure: antibiotics BEFORE, no exceptions
  • Kyphoplasty: balloon first → cavity → cement (possible height restoration)
  • Vertebroplasty: direct cement injection (more leak risk)
  • Cement epidural leak → stop immediately + neuro check
  • Core needle = histology  |  FNA = cytology only
Build Your Exam
Choose categories, set question count, and configure your session
Question Pool
778 Questions
Available to draw from
All categories selected
Content Categories
Exam Options
Number of Questions
Max determined by selected categories
Show answers as you go
See explanation immediately after each answer
Include timer
60 seconds per question — auto-advances when time runs out
Category Breakdown
Approximate · weighted draw
ARRT® Mock Registry Exam
160 questions · Weighted to ARRT® proportions · Scored by category
Exam Breakdown
Category Questions Weight
Patient Care2214%
Image Production2616%
Vascular Diagnostic4226%
Vascular Interventional4226%
Nonvascular2818%
Total 160 100%
Complete in one session. Leaving mid-exam forfeits your score. Questions are randomly drawn and cannot be paused.
Exit Mock Exam?
If you leave now, your session will be permanently discarded.
Your answers will not be saved and this attempt will not count toward your scores.
Q 1 / 15
Explanation
0%
Quiz Complete
0Correct
0Wrong
0Total
Flashcards
Active recall from all 778 exam questions — flip each card to reveal the answer
1 / 20
Question
tap card to reveal answer
Answer
Quick Reference
ACR, SIR, NCRP, and textbook-verified — the facts you need to memorize

Lab Values & Procedural Thresholds

TestNormalThreshold & Use
INR0.8–1.2<2.0 low-risk / <1.5 moderate & high-risk (SIR)
aPTT25–35 sec50–100 sec = therapeutic IV UFH
ACT70–120 sec>200 sec = procedural anticoagulation (tableside)
Platelets150–400 K/µL>50,000 required for all IR procedures
Creatinine0.6–1.2 mg/dLElevated → eGFR → CIN risk assessment
eGFR>60 mL/min<30 = high CIN risk → IOCM or CO₂
K⁺3.5–5.0 mEq/LCorrect if abnormal — arrhythmia risk with sedation
Source: SIR consensus guidelines and ACR clinical standards · SIR Consensus Guidelines JVIR 2019

Contrast Reactions — ACR 2023 Treatment

SeverityKey SignsTreatment
MildLimited urticaria, flushing, nauseaObserve. Diphenhydramine 25–50mg PRN.
ModerateDiffuse urticaria, mild bronchospasmO₂, IV fluids, Benadryl 50mg IV. Epi IM if progressing.
AnaphylaxisBronchospasm, collapse, tachycardiaEpinephrine FIRST: 0.3mg IM (1:1,000) or 0.1mg IV (1:10,000)
VasovagalBradycardia + hypotensionLegs up, fluids, O₂, Atropine 0.5–1mg IV. NOT epi.
CINCr ↑ ≥0.3mg/dL in 48hPre-hydration NS, minimize contrast, IOCM, hold metformin
Source: ACR Manual on Contrast Media 2023

Medications & Reversal Agents

DrugUse & DoseReversal
Heparin (UFH)Procedural anticoag. ACT monitoring.Protamine 1mg per 100U UFH
Alteplase (tPA)CDT 0.5–1mg/hr via catheterFFP/cryoprecipitate (no specific reversal)
FentanylOpioid — 100× potency of morphineNaloxone 0.4–2mg IV
Midazolam (Versed)Benzo — anxiolysis/amnesiaFlumazenil 0.2mg IV (max 1mg)
EpinephrineAnaphylaxis — 0.3mg IM (1:1,000)N/A
AtropineVasovagal bradycardia — 0.5–1mg IVN/A
NitroglycerinArterial spasm — 100–200mcg IAN/A
MethylprednisoloneContrast premedication — 32mg PO ×2N/A

Radiation Protection — NCRP Limits

ParameterLimit
Occupational whole body (annual)50 mSv/year (5 rem)
Occupational lens of eye150 mSv/year
Occupational extremity500 mSv/year
Declared pregnancy (total)5 mSv entire pregnancy
Patient reporting threshold≥5 Gy cumulative air kerma
DAP unitsmGy·cm²
TLD advantageCan be re-read; accurate integrated dose
Source: NCRP Reports 116 & 168 · Joint Commission

Key Procedures — Access, Goals & Complications

ProcedureAccessTechnical GoalKey Complication
TIPSRight IJV → hepatic vein → portal vein (transhepatic)PSG <12 mmHgHepatic encephalopathy (25–35%)
IVC FilterRight femoral or IJV. Infrarenal below lowest renal vein.PE prevention (cavagram first)Filter fracture, IVC thrombosis, perforation
NephrostomyPosterior lower pole calyx. Prone. US + fluoro.Decompress obstructed systemHemorrhage (most common), urosepsis
Biliary Drain (PTCD)Transhepatic right lobe. Prophylactic Abx mandatory.Decompress obstructed bile ductBiliary sepsis (most dangerous)
VertebroplastyTranspedicular under fluoroscopyPain relief in VCFPMMA cement leak → epidural or PE
TACECFA → hepatic artery → tumor feederTumor devascularization + local chemoPost-embolization syndrome (expected)
Y-90CFA → hepatic artery (after MAA shunt study)Radiation delivery to tumorRadiation pneumonitis if shunt >20%
Carotid Stenting (CAS)CFA → aorta → carotid with distal EPDStent across stenosis with EPD deployedStroke/TIA from distal embolization
Tunneled HD CatheterRight IJV preferred. Subcutaneous tunnel.Tip at SVC-RA junctionFibrin sheath, infection, thrombosis
Percutaneous GastrostomyAir insufflation + T-fastener gastropexySecure tube through gastropexied stomachPeritonitis (pneumoperitoneum >48h)
Sources: SIR consensus guidelines · SIR Clinical Practice Guidelines · AASLD Guidelines · ACR Manual on Contrast Media · NCRP Report 168

Vascular Anatomy — Key Facts & Variants

StructureOrigin / LevelKey Clinical Fact
Celiac trunkAnterior aorta at T12–L1Trifurcation: left gastric + splenic + common hepatic (~89%)
Replaced RHAFrom SMA (10–15%)Most common hepatic variant — must identify before TACE
Replaced LHAFrom left gastric (~10%)Second most common — runs in lesser omentum
Michels Type IXEntire hepatic supply from SMANo hepatic branches on celiac arteriogram — check SMA
SMA originAnterior aorta at L1Passes anterior to D3 (duodenum); arc of Riolan = SMA–IMA collateral
IVC formationL4–L5 confluence of common iliac veinsAscends RIGHT of aorta; passes through T8 caval hiatus
Duplicated IVCPrevalence 0.2–3%Bilateral filters OR suprarenal filter required
Left-sided IVCPrevalence 0.2–0.5%Joins left renal vein → crosses anterior to aorta → right suprarenal IVC
Circumaortic LRVPrevalence 2.4–8.7%Two left renal veins encircle aorta — alters filter placement zone
Portal veinSMV + splenic vein posterior to pancreatic neck at L1–L2IMV drains into splenic vein (not portal confluence directly)
Left renal veinCrosses anterior to aortaReceives left gonadal + left adrenal + left phrenic veins
Right adrenal vein3–5mm — drains directly into IVCMost challenging AVS catheterization; right IVC posterolateral wall
Aortic arch branchesProximal to distal1. Brachiocephalic → 2. Left CCA → 3. Left subclavian
Vertebral arteriesFrom subclavian arteries bilaterallyUnite at pontomedullary junction → basilar artery; left dominant ~45%
CCA bifurcationC3–C4 (upper thyroid cartilage)ICA = posterior/lateral; ECA = anterior/medial; carotid body here
Anterior communicating arteryBetween bilateral ACAsMost common intracranial aneurysm site (~30–35%)
SFA → popliteal transitionAdductor (Hunter's) canal → adductor hiatusCommon SFA occlusion site due to repetitive flexion stress
Popliteal trifurcationLower popliteal fossa / proximal fibular headAT → anterior; Tibioperoneal trunk → PT + peroneal
Uterine arteryAnterior division of internal iliac'Water under bridge' — crosses superior to ureter
Artery of AdamkiewiczLeft T8–L1 intercostal/lumbar (75%)Dominant anterior spinal feeder — TEVAR coverage → spinal ischemia
Right IPARight inferior phrenic arteryMost common extrahepatic HCC feeder (hepatic dome, seg VII/VIII)
Internal iliac projections25° RAO → left IIA in profile; 25° LAO → right IIA in profileCounterintuitive — contralateral oblique profiles each IIA
Sources: StatPearls (NBK534861, NBK459241, NBK430539) · PMC4862848 · PMC10788309 · RadioGraphics IVC variants 2014 · ASRT VIE Module Transcripts 2016 · Song et al. Radiology 2010

Patient Prep — NPO, Consent & Monitoring

TopicKey RuleSource
NPO — Clear liquids2 hours minimum before procedureASA guidelines
NPO — Light meal6 hours minimumASA guidelines
NPO — Full meal8 hours minimumASA guidelines
Informed consentMust be obtained BEFORE sedation; covers risks, benefits, alternatives, right to refuseJCAHO
Emergent (implied) consentIncapacitated patient + life-threatening emergency; document absence of surrogateLegal standard
Universal time-outEntire team together, immediately before procedure; patient ID + procedure + site confirmedJC Universal Protocol
Allen test normalColor returns to palm within 7 seconds after releasing ulnar arteryStandard technique
Barbeau Type DSpO₂ waveform lost and does NOT recover → radial access CONTRAINDICATEDBarbeau 2001
EtCO₂ normal35–45 mmHg; flat waveform = apnea (detects 30–90s before SpO₂ drops)AANA standards
Controlled substance wasteTwo qualified staff witness AND sign; physical waste immediately; no savingDEA 21 CFR
Lead apron inspectionVisual each use; fluoroscopic/radiographic annually; never fold — always hangNCRP / facility policy
Metformin + contrastHold 48h if eGFR <60 after contrast; resume when renal function confirmed stableACR guidelines
Sources: ASA NPO guidelines · ACR guidelines · JC Universal Protocol · NCRP · DEA 21 CFR 1301
Performance Analytics
Track your progress across all content areas